DNA enzyme shuffles cell membranes a thousand times faster than its natural counterpart

Liz Ahlberg Touchstone for the Illinois News Bureau
6/21/2018

Postdoctoral researcher Christopher Maffeo and physics professor Aleksei Aksimentiev used the Blue Waters supercomputer to model synthetic DNA enzymes. Photo by L. Brian Stauffer, University of Illinois at Urbana-Champaign
Postdoctoral researcher Christopher Maffeo and physics professor Aleksei Aksimentiev used the Blue Waters supercomputer to model synthetic DNA enzymes. Photo by L. Brian Stauffer, University of Illinois at Urbana-Champaign
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells.   

Researchers at University of Illinois at Urbana-Champaign and the University of Cambridge say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitude. They published their findings in the journal Nature Communications.

“Cell membranes are lined with a different set of molecules on the inside and outside, and cells devote a lot of resources to maintaining this,” said study leader Aleksei Aksimentiev, a professor of physics at Illinois. “But at some points in a cell’s life, the asymmetry has to be dismantled. Then the markers that were inside become outside, which sends signals for certain processes, such as cell death. There are enzymes in nature that do that called scramblases. However, in some diseases where scramblases are deficient, this doesn’t happen correctly. Our synthetic scramblase could be an avenue for therapeutics.”

Aksimentiev’s group came upon DNA’s scramblase activity when looking at DNA structures that form pores and channels in cell membranes. They used the Blue Waters supercomputer at the National Center for Supercomputing Applications at Illinois to model the systems at the atomic level. They saw that when certain DNA structures insert into the membrane – in this case, a bundle of eight strands of DNA with cholesterol at the ends of two of the strands – lipids in the membrane around the DNA begin to shuffle between the inner and outer membrane layers.

See an animation at https://youtu.be/kGgTIFYbUko.

To verify the scramblase activity predicted by the computer models, Aksimentiev’s group at Illinois partnered with professor Ulrich Keyser’s group at Cambridge. The Cambridge group synthesized the DNA enzyme and tested it in model membrane bubbles, called vesicles, and then in human breast cancer cells.

A synthetic DNA enzyme inserts into a cell membrane, causing lipids to shuffle between the inner and outer membrane layers.

Image courtesy of Christopher Maffeo
A synthetic DNA enzyme inserts into a cell membrane, causing lipids to shuffle between the inner and outer membrane layers. Image courtesy of Christopher Maffeo
“The results show very conclusively that our DNA nanostructure indeed facilitates rapid lipid scrambling,” said Alexander Ohmann, a graduate student at Cambridge and a co-first author of the paper along with Illinois graduate student Chen-Yu Li. “Most interestingly, the high flipping rate indicated by the molecular dynamics simulations seems to be of the same order of magnitude in experiments: up to a thousand-fold faster than what has previously been shown for natural scramblases.”

On its own, the DNA scramblase produces cell death indiscriminately, Aksimentiev said. The next step is to couple it with targeting systems that specifically seek out certain cell types, a number of which have already been developed for other DNA agents.

“We are also working to make these scramblase structures activated by light or some other stimulus, so they can be activated only on demand and can be turned off,” Aksimentiev said.

“Although we have still a long way to go, this work highlights the enormous potential of synthetic DNA nanostructures with possible applications for personalized drugs and therapeutics for a variety of health conditions in the future,” Ohmann said.

The U.S. National Science Foundation and the National Institutes of Health supported this work.  

Recent News

  • In the Media

As the chair of the NASA Fundamental Physical Sciences  Review Board, which has oversight responsibility for the recently launched Cold Atom Laboratory (CAL), Professor Brian DeMarco plays a seminal role in the "Coolest Experiment in the Universe," taking place on the International Space Station. DeMarco is featured in the video released in conjunction with this press release. The ultra-cold-atom experiment will study a Bose-Einstein condensate in space to uncover a new understanding of its properties and interactions at a temperature barely above absolute zero.

  • Accolades

Professor Peter Abbamonte has been named the Fox Family Professor in Engineering at the University of Illinois at Urbana-Champaign. Named faculty appointments signify a distinction beyond that of professorial rank, recognizing distinguished scholars for their prominence in research, teaching, and service.

  • In the Media

A second solar farm planned in Savoy will put the University of Illinois in the lead among American universities in terms of solar energy, a top campus proponent says.

The campus is moving ahead with a 55-acre solar farm along the north side of Curtis Road, between First and Neil streets in Savoy, about a mile south of the first 21-acre farm on Windsor Road.

Physics Professor Scott Willenbrock, who recently served as a provost's fellow for sustainability, briefed the Academic Senate about the project Monday, saying it will help the campus meet its goal of generating 5 percent of its energy needs from renewable sources. That target was part of the Illinois Climate Action Plan, known as iCap.

  • Research
  • Biological Physics

A previously unappreciated interaction in the genome turns out to have possibly been one of the driving forces in the emergence of advanced life, billions of years ago.

This discovery began with a curiosity for retrotransposons, known as “jumping genes,” which are DNA sequences that copy and paste themselves within the genome, multiplying rapidly. Nearly half of the human genome is made up of retrotransposons, but bacteria hardly have them at all.

Nigel Goldenfeld, Swanlund Endowed Chair of Physics and leader of the Biocomplexity research theme at the IGB, and Thomas Kuhlman, a former physics professor at Illinois who is now at University of California, Riverside, wondered why this is.“We thought a really simple thing to try was to just take one (retrotransposon) out of my genome and put it into the bacteria just to see what would happen,” Kuhlman said. “And it turned out to be really quite interesting.”